Literature DB >> 11895457

Serum angiogenin concentrations in young patients with diabetes mellitus.

F Chiarelli1, M Pomilio, A Mohn, S Tumini, A Verrotti, A Mezzetti, F Cipollone, M Wasniewska, G Morgese, A Spagnoli.   

Abstract

BACKGROUND: Angiogenin serum levels were measured in a large group of type 1 diabetic young patients, looking at whether increased Angiogenin concentrations are associated with long-term glycemic control and microvascular complications.
MATERIALS AND METHODS: Four groups of patients were compared to 223 age- and sex- matched healthy controls: 196 type 1 diabetic patients (age range 3-24 years, onset of diabetes before the age of 12 years; duration of disease longer than 2 years), without microvascular complications were divided into three groups on the basis of age (group 1, n = 37, age < 6 years; group 2, n = 71, age 6-12 years; group 3, n = 88, age > 12 years); 53 adolescents and young adults (age 16.1-29.7 years) with diabetic microvascular complications (background, preproliferative or proliferative retinopathy, albumin excretion rate 20-200 microg min-1) (group 4).
RESULTS: Angiogenin serum levels were significantly increased in diabetic pre-school and pre-pubertal children, and particularly elevated in pubertal subjects compared with age- and sex-matched controls. Adolescents and young adults with microvascular complications had very high angiogenin concentrations. One-year mean HbA1c values were correlated with angiogenin levels (r = 0.389; p < 0.01). In poorly controlled diabetics (HbA1c > 10%), long-term (2 years) improvement of glycemic control determined a significant reduction of angiogenin concentrations in both pre-school and pre-pubertal children as well as in pubertal youngsters.
CONCLUSIONS: Angiogenin serum concentrations are increased in diabetic children even before puberty. Severity of microvascular complications is associated with markedly increased angiogenin serum levels. Long-term tight glycemic control determines a consistent reduction of angiogenin concentrations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895457     DOI: 10.1046/j.0014-2972.2001.00958.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  14 in total

1.  Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats.

Authors:  Jieli Chen; Xinchun Ye; Tao Yan; Chunling Zhang; Xiao-Ping Yang; Xu Cui; Yishen Cui; Alex Zacharek; Cynthia Roberts; Xinfeng Liu; Xiangguo Dai; Mei Lu; Michael Chopp
Journal:  Stroke       Date:  2011-09-22       Impact factor: 7.914

Review 2.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

Review 3.  Functional roles of the human ribonuclease A superfamily in RNA metabolism and membrane receptor biology.

Authors:  Heng-Huan Lee; Ying-Nai Wang; Mien-Chie Hung
Journal:  Mol Aspects Med       Date:  2019-03-25

4.  Erythropoietin ameliorates the reduced migration of human fibroblasts during in vitro hypoxia.

Authors:  Stephanie Breit; Monika Bubel; Tim Pohlemann; Martin Oberringer
Journal:  J Physiol Biochem       Date:  2010-09-04       Impact factor: 4.158

5.  Serum angiogenin in inflammatory bowel disease.

Authors:  Ioannis E Koutroubakis; Costas Xidakis; Konstantinos Karmiris; Aekaterini Sfiridaki; Ermioni Kandidaki; Elias A Kouroumalis
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

6.  The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet's disease.

Authors:  Ali Yalçındağ; Yeşim Gedik-Oğuz; F Nilüfer Yalçındağ
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-04       Impact factor: 3.117

Review 7.  Three decades of research on angiogenin: a review and perspective.

Authors:  Jinghao Sheng; Zhengping Xu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-12-23       Impact factor: 3.848

8.  Angiogenin secretion from hepatoma cells activates hepatic stellate cells to amplify a self-sustained cycle promoting liver cancer.

Authors:  Cristina Bárcena; Milica Stefanovic; Anna Tutusaus; Guillermo A Martinez-Nieto; Laura Martinez; Carmen García-Ruiz; Alvaro de Mingo; Juan Caballeria; José C Fernandez-Checa; Montserrat Marí; Albert Morales
Journal:  Sci Rep       Date:  2015-01-21       Impact factor: 4.379

9.  Early Onset Age Increased the Risk of Diabetic Retinopathy in Type 2 Diabetes Patients with Duration of 10-20 Years and HbA1C ≥7%: A Hospital-Based Case-Control Study.

Authors:  Jing Yuan; Lin Zhang; Pu Jia; Zhong Xin; Jin-Kui Yang
Journal:  Int J Endocrinol       Date:  2021-06-10       Impact factor: 3.257

10.  Changes of serum angiogenic factors concentrations in patients with diabetes and unstable angina pectoris.

Authors:  Chun Gui; Shi-kang Li; Qin-ling Nong; Fang Du; Li-guang Zhu; Zhi-yu Zeng
Journal:  Cardiovasc Diabetol       Date:  2013-02-19       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.